NCT07167966: Alzheimer's Tau Platform: Regimen A - AADvac1
- State
- Under way
- Phase
- Phase 2
- People
- 450 planned
- Started
- 3 Nov 2026
- Primary completion
- 31 Aug 2028
- Arms
- AADvac1 monotherapy, Combination AADvac1 therapy with donanemab
- Results
- None posted
- 11 Sep 2025: Trial registered